Ultrasound Contrast Agent Safe During Stress Echocardiogram

Key points
- Research conducted at the Methodist DeBakey Heart & Vascular Center in Houston shows that the use of ultrasound contrast agents during stress echocardiograms is safe.
- The risk of major adverse effects is no different in patients that received contrast during their stress echocardiogram than in those who did not receive contrast, according to research findings.
- “Contrast-enhanced stress echocardiography is a safe option to attain important diagnostic information for patients who need more testing than cardiac ultrasound alone,” said Dr.
- Contrast, a liquid that is clearly visible in imaging studies such as echocardiograms, is injected into the heart to enhance the quality of the image.
Research conducted at the Methodist DeBakey Heart & Vascular Center in Houston shows that the use of ultrasound contrast agents during stress echocardiograms is safe. These results, revealed at the 19th Annual Scientific Sessions of the American Society of Echocardiography, come just months after the U.S. Food and Drug Administration mandated a black box warning on labels of contrast agents used for cardiovascular ultrasound.
The risk of major adverse effects is no different in patients that received contrast during their stress echocardiogram than in those who did not receive contrast, according to research findings. This held true even though contrast was more often used in patients with a higher cardiac risk profile.
“Contrast-enhanced stress echocardiography is a safe option to attain important diagnostic information for patients who need more testing than cardiac ultrasound alone,” said Dr. Kamran Shaikh, postdoctoral echocardiography fellow at the Methodist DeBakey Heart & Vascular Center. “Our research found no link between its use and adverse events or any reason why it shouldn’t be available to cardiologists whose patients would benefit from it.”
Contrast, a liquid that is clearly visible in imaging studies such as echocardiograms, is injected into the heart to enhance the quality of the image.
The study examined 3,121 consecutive patients who underwent stress echocardiograms from 2002 through 2007 at The Methodist Hospital.
Researchers evaluated demographics, contrast use, hemodynamics, ECG and wall motion changes, symptoms and arrhythmias. Contrast was administered in 1,879 of 3,121 patients (60 percent). None of the patients receiving an ultrasound contrast agent experienced sustained ventricular tachycardia, ventricular fibrillation, cardiac arrest or death.
The research was conducted by Drs. Kamran Shaikh, Su Min Chang, Kathleen Rosendahl-Garcia, Miguel A. Quiñones, Sherif F. Nagueh, Karla M. Kurrelmeyer and William A. Zoghbi at Methodist DeBakey Heart & Vascular Center.
Source: Methodist Hospital, Houston
Written and revised by
David Cohen, M.D.
Our doctors write and review articles for accuracy and keep them up to date.
health.am provides general information, not medical advice. Always consult a qualified health professional about your own health.
Explore health topics
More in this topic
Heart & Blood Vessels →
NewsCholesterol drugs safe, even after a decade of use
Cholesterol-lowering drugs continue to produce benefits without any serious safety problems, such as increased cancer risk, even after more than a decade of use, researchers said Wednesday. The finding from a large…
24 November 2011
NewsHeart transplant surgery safe and effective: A Canadian retrospective spanning 3 decades
Heart transplantation is a very safe and effective therapy, according to a new long-term study presented today at the Canadian Cardiovascular Congress 2011, co-hosted by the Heart and Stroke Foundation and the Canadian…
24 October 2011
NewsVaricose Veins - EVLT And HLS Have Similar Efficacy And Safety Rates
HLS (High ligation and stripping) and EVLT (endovenous laser treatment) have similar efficacy and safety rates in the treatment of insufficiency of the great saphenous vein (GSV), but there are slightly more cases of…





